That is the short answer. The longer answer is about pattern, timing and context, because the same two numbers move for muscle, alcohol, fat in the liver and a dozen other reasons. The sections below walk through how a stone does it, what the rest of the liver panel tends to show, and what a clinician checks next.
Both are enzymes that sit inside cells and leak into the bloodstream when those cells are stressed or injured. ALT is concentrated mostly in liver cells, which makes it fairly liver specific. AST is in liver cells too, but also in heart muscle, skeletal muscle, kidney and red blood cells, so it is less specific to the liver on its own. Neither enzyme measures how well the liver is working. They are leakage signals, not function scores, and they move for many reasons.
The full breakdown of what the test is, how the sample is drawn, what a single value means in isolation and how the number is framed against reference ranges lives on the AST biomarker page linked above. Everything that follows here stays on the question asked, which is what gallstones do to these two enzymes.
It raises them by blocking the drainage system that the liver empties into. Bile made by liver cells flows down small ducts, collects in the common hepatic duct, and runs into the common bile duct before emptying into the small intestine. The gallbladder hangs off this system through the cystic duct and acts as a holding tank. A stone formed in the gallbladder can slip into the cystic duct or travel further into the common bile duct.
When a stone wedges in the common bile duct, bile cannot drain. Pressure builds backwards up the duct system and into the liver itself. That back pressure stresses the cells lining the ducts and the liver cells around them, and stressed cells leak their contents. AST and ALT spill into the blood as a result, which is why a plumbing problem outside the liver can produce numbers that look like liver injury.
Two things follow from this mechanism. First, the rise is usually fast, because the pressure change is sudden rather than gradual. Second, it is tied to obstruction, not to the existence of stones. A gallbladder full of stones that never leave the gallbladder does not generate that back pressure, which is why so many people with stones have perfectly ordinary liver enzymes for years.
The retained bile components themselves also irritate liver tissue, and a duct that is blocked for longer gives bacteria an easier route to cause infection. Both of those add to the enzyme picture and to how someone feels, which is part of why pain plus fever plus yellowing of the skin or eyes is treated as a time-sensitive combination rather than something to watch at home.
Location is almost everything. The same stone produces a completely different lab picture depending on where it stops.
Stones sitting in the gallbladder with no symptoms are the most common situation, and liver enzymes are usually normal, because nothing is obstructed. A stone that temporarily blocks the cystic duct causes the classic right upper quadrant pain after a meal. In that situation AST and ALT are often normal or only slightly up, since the main bile drainage route from the liver is still open. If the gallbladder becomes inflamed, enzymes can nudge higher as nearby tissue is involved.
A stone that reaches the common bile duct is the scenario that moves transaminases most. Here the liver's own drainage is blocked, bilirubin can climb, and the enzyme picture changes quickly. Research suggests that abnormal liver tests, pancreatitis and gallbladder inflammation before gallbladder surgery are associated with the presence of common bile duct stones, although abnormal results also show up in people who turn out to have no duct stone at all 1.
A stone that lodges right at the outlet where the bile duct and the pancreatic duct meet can block pancreatic drainage too, which is why pancreatic enzymes are often checked in the same blood draw as AST and ALT.
So the practical answer is that gallstones cause a transaminase rise mainly when they migrate. The number on the report reflects obstruction and irritation, not stone count.
A duct stone usually leaves fingerprints across several markers at once, not just on two enzymes. Alkaline phosphatase (ALP) and gamma glutamyl transferase (GGT) come from the bile duct lining and tend to climb when drainage is obstructed. Bilirubin rises when bile cannot clear, which is what produces visible yellowing. AST and ALT are the hepatocellular pair, and they can spike sharply and early in a sudden blockage before the duct markers have caught up.
That early sequencing surprises people. A blood draw taken soon after a stone impacts can show high transaminases with an ALP and bilirubin that are still close to normal, which can read as a liver problem rather than a bile duct problem. A draw taken a day or two later in the same person can show the reverse, with transaminases falling while ALP, GGT and bilirubin are still rising.
| Pattern across the panel | What the numbers often look like | What it may reflect | Sensible next step |
|---|---|---|---|
| Sharp AST and ALT rise, ALP and bilirubin near normal | Transaminases well above the lab's upper limit, other markers lagging | A recent, sudden obstruction, sometimes a stone that has already moved | Repeat labs on a clinician's timeline, plus imaging of the biliary tree |
| AST, ALT, ALP, GGT and bilirubin all up | A mixed picture with both cell leakage and blocked drainage | Ongoing obstruction of the common bile duct | Prompt clinical review and imaging |
| ALP and GGT up, AST and ALT near normal | Duct markers lead, transaminases quiet | A drainage or duct issue rather than cell injury | Clinician review of bile duct and other causes |
| AST up, ALT normal, duct markers normal | An isolated AST elevation | A source outside the liver such as muscle, after hard training or injury | Discuss muscle markers and recent activity with a clinician |
A meta-analysis of predictors before gallbladder surgery found that features such as jaundice, cholangitis and raised bilirubin or alkaline phosphatase are associated with common bile duct stones, while no single clinical or laboratory predictor was accurate enough to stand alone 2.
Read it against the lab's own range first, then against the clinical picture, then against the trend. Reference ranges differ between laboratories because they use different analysers and different reference populations, and they shift with age and sex. The table below gives typical lab reference ranges, and FitScript's optimal range where one is defined.
| Marker | Typical lab reference range | FitScript optimal range |
|---|---|---|
| AST (SGOT) | 10 to 40 U/L | 10 to 25 U/L |
| ALT (SGPT) | Commonly around 7 to 56 U/L, lower upper limits at many labs for women | Use your lab's range |
| ALP | Commonly around 44 to 147 U/L | Use your lab's range |
| Total bilirubin | Commonly around 0.1 to 1.2 mg/dL | Use your lab's range |
| GGT | Varies widely by lab, age and sex | Use your lab's range |
These are typical lab reference ranges, and they vary by lab, age and sex, so the range printed on your own report is the one that applies to your sample. FitScript's optimal range is an optimization target, not a diagnostic cut-off, and a value outside it is a prompt for conversation rather than a conclusion.
Two reading habits help. A mildly elevated value with no symptoms is a different conversation from a sharply elevated value with pain, and the size of the jump from a person's own previous results often carries more information than the distance from the top of the range. A result that is suboptimal and stable over a year raises different questions from one that has tripled since the last draw.
Because the obstruction can resolve on its own. Stones in the common bile duct are not always permanently stuck. A small stone can pass through the duct outlet into the intestine, pressure drops, bile drains again, and the liver cells stop leaking. The enzymes that spilled during the blocked period then clear from the blood over the following days.
This matters for interpretation more than almost anything else on the page. Research suggests that common bile duct stones have a variable natural history, with stones that pass spontaneously as well as stones that persist and stones that cause no symptoms, which makes prediction from any single snapshot difficult 4. A blood draw taken after a stone has already passed can look far milder than the episode that produced it.
The practical consequences are worth spelling out. A normal liver panel does not prove a stone never blocked the duct, especially after an episode of severe pain that settled on its own. Likewise, a falling set of enzymes does not by itself prove the duct is clear, because another stone may still be sitting in the gallbladder waiting to follow the first one. This is a large part of why a clinician will often ask for both repeat bloods and imaging rather than acting on the first result in isolation.
No. They raise or lower the probability, but they do not settle the question. A Cochrane review comparing ultrasound with liver function tests for diagnosing common bile duct stones concluded that neither test was accurate enough on its own to confirm or exclude stones, so people with suspected stones generally need further imaging 3.
Older work reached the same conclusion from a different angle. Studies indicate that prediction of duct stones from ultrasound findings and liver function tests is imperfect when checked against direct imaging of the bile duct 6. In plain terms, enzymes are a useful signal and a poor verdict.
That is why clinicians think in probabilities. A person with severe pain, jaundice, a dilated duct on ultrasound and a rising bilirubin sits in a high probability group. A person with a single mildly raised ALT, no pain and a normal ultrasound sits in a low probability group, and the useful next step may be a repeat test rather than more scanning. Most people fall between those extremes, which is exactly where additional imaging earns its place.
It also explains why your result should be read by someone who can see the whole picture. Discuss any abnormal liver result with a clinician or licensed provider who can combine the numbers with your symptoms, your history and your imaging.
Imaging of the biliary tree, chosen according to how likely a duct stone looks.
Magnetic resonance cholangiopancreatography produces a detailed map of the ducts without instruments entering the body, and endoscopic ultrasound examines the lower bile duct from inside the gut. European guidance on the endoscopic management of common bile duct stones describes stratifying people by probability using features such as liver tests, bilirubin and ultrasound findings, and reserving endoscopic ultrasound or magnetic resonance imaging for those at intermediate probability 5.
Alongside imaging, repeat bloods map the direction of travel. A clinician may also request pancreatic enzymes, a full blood count, inflammatory markers, albumin and clotting tests, because those describe how the body is coping rather than just what is leaking. None of this is something to arrange from a search result. Which scan, in which order, and what happens afterwards is a decision for the clinician who examines you.
Plenty, which is the main reason a single high value is never a diagnosis. The most common contributors fall into a few groups.
Fat accumulation in the liver is the quietest and most frequent cause of mildly raised ALT in adults, and it usually produces modest, persistent elevations rather than sudden spikes. Alcohol intake affects both enzymes and tends to push AST relatively higher than ALT. Viral hepatitis can produce large rises. Autoimmune and inherited conditions affecting the liver, iron overload among them, show up on this panel too.
Then there are sources outside the liver. AST lives in skeletal muscle, so a hard training session, a long run, a heavy lift or a muscle injury can lift it with a completely healthy liver. Breakdown of red blood cells in the sample tube can falsely raise AST as well, which is one reason a strange isolated result is often repeated before anything else happens. Thyroid problems and coeliac disease can also show up as unexplained transaminase elevation.
Some medicines and over the counter products affect these enzymes, and that is a review for the clinician who knows your full list rather than something to work out alone. Bring every prescription, supplement and herbal product to that conversation, including anything taken occasionally.
The useful habit is to ask what else was happening around the draw. Sudden severe right upper abdominal pain the night before points in a very different direction from a heavy leg session the morning before.
The markers that separate a drainage problem from a cell injury problem, and liver sources from non-liver sources. A sensible companion set includes ALP and GGT for the bile ducts, total and direct bilirubin for clearance, albumin and prothrombin time for how well the liver is actually functioning, and a full blood count with inflammatory markers when infection is a question.
Pancreatic enzymes matter when a stone may have reached the duct outlet. Creatine kinase helps when AST is raised and the liver markers around it are not, because a muscle source becomes much more plausible when creatine kinase is high too. Over a longer horizon, markers of metabolic health such as fasting insulin, triglycerides, HDL and HbA1c give context for fat in the liver, which is the background cause behind many mildly elevated ALT results that have nothing to do with stones.
Testing these together is far more informative than chasing one enzyme in isolation. FitScript builds around that idea, with 150+ biomarkers tested per year and interpretation by Atlas, FitScript's AI health advisor, so a liver enzyme sits in a panel rather than on its own line. Any decision about care that follows is made by a licensed provider who reviews the member.
Work through it in three steps. The observation is the number itself, read against the lab's range and against your own previous results. The meaning is a set of possibilities rather than a single answer, since a raised AST and ALT may reflect a duct obstruction, fat in the liver, alcohol intake, a muscle source, a viral cause or a recent medication change. The next step is the part you control, which is getting the result in front of a clinician with the context that makes it interpretable.
Bring the specifics to that appointment. Note when the pain started if there was pain, what it felt like, whether it radiated to the back or shoulder blade, whether fever or vomiting came with it, whether urine darkened or stools lightened, what you ate, what you drank and what training you did in the days before the draw. Those details change the probability far more than a few units on the report.
What not to do is also worth saying. Do not treat a normal repeat result as a clean bill of health after a severe pain episode, and do not ignore an abnormal result because you feel fine today. A value that is clearly outside the standard range with symptoms alongside it is worth discussing with a clinician promptly rather than at the next routine visit.
When symptoms join the numbers. Severe abdominal pain together with fever, yellowing of the skin or eyes, persistent vomiting, chills or confusion needs urgent in person assessment, not a blood test booked for next week. That combination can signal a blocked and infected bile duct, which is a situation clinicians act on quickly.
Other signals that warrant prompt rather than routine attention include pain that lasts for hours instead of settling, dark urine with pale stools, and a bilirubin that is climbing across repeat draws. Research suggests that jaundice and cholangitis are among the features associated with common bile duct stones, which is part of why they prompt faster assessment 2.
At the other end, a mildly suboptimal ALT found on a routine panel in someone who feels well is usually a conversation rather than an emergency. It still deserves follow up, because the common quiet causes of that pattern are worth identifying early.
This article is educational and is not medical advice.
It turns a snapshot into a trend, which is where these two enzymes earn their value. After a suspected stone episode, serial measurements show whether the numbers are falling, holding or climbing, and that direction informs how urgently anything else is needed. A plateau at a raised level raises the question of a second cause sitting underneath the first.
Longer term, a baseline matters. Someone who knows their usual ALT across several years can recognise a meaningful change immediately, while someone with a single result has no way to tell a new problem from their normal. This is the strongest argument for routine panels rather than testing only when something hurts.
Frequency is a clinical decision. How soon to repeat, what to add and when to stop checking depends on the suspected cause, the symptoms and the imaging, and that belongs to the clinician managing your care rather than to a fixed schedule from an article.
For a deeper look at the test itself and how its results are framed, see what is sgot ast blood test, and for how to judge the scale of an elevation in the liver specific enzyme, see when to worry about alt levels.
No. Stones that stay inside the gallbladder usually leave both enzymes normal, because nothing is blocking the flow of bile out of the liver. Enzymes tend to move when a stone migrates into the common bile duct and obstructs drainage.
They can rise well above the top of the lab reference range, sometimes several times higher, and the size of the rise does not identify the cause by itself. A clinician reads the number alongside symptoms, the rest of the liver panel and imaging before drawing any conclusion.
Yes. If the stone passes into the intestine, pressure in the duct falls and the enzymes clear from the blood, so a sample taken afterwards can look unremarkable. That is why a normal result after a severe pain episode does not close the question.
Alkaline phosphatase, gamma glutamyl transferase and bilirubin describe the bile duct side of the picture. Albumin and clotting tests show how the liver is functioning, pancreatic enzymes matter when a stone may have reached the duct outlet, and creatine kinase helps when a muscle source is possible.
AST is present in muscle, heart and red blood cells as well as the liver, so hard training, a muscle injury or breakdown of cells in the sample tube can lift it on its own. An isolated AST elevation with a normal ALT often points away from the liver, and is worth repeating under a clinician's guidance.
It varies a great deal from person to person and depends on whether the duct has cleared. Some values fall noticeably over days once bile is draining again, while others stay raised because another cause is present. The clinician managing your care decides when to recheck.
Liver enzymes are usually rechecked after any procedure involving the biliary system, and results differ between people. Persistent elevation afterwards is a reason to look again at the bile duct and at other causes, which is a conversation for the surgical or medical team involved.
Sometimes. A panel that includes AST, ALT, alkaline phosphatase, gamma glutamyl transferase and bilirubin can show a pattern worth investigating, and having earlier results to compare against makes a new change easier to spot. Any abnormal result should be reviewed by a clinician or licensed provider who can see your full history.